Elevated concentrations of circulating adhesion molecules and their association with microvascular complications in insulin-dependent diabetes mellitus

The Journal of Clinical Endocrinology and Metabolism
P FaschingOswald F Wagner

Abstract

To better understand potential associations of circulating adhesion molecules (cAMs) with diabetic microangiopathy, circulating serum concentrations of intercellular adhesion molecule-1 (cICAM-1), vascular cell adhesion molecule-1 (cVCAM-1), and endothelial leukocyte adhesion molecule-1 (cELAM-1) were determined in patients with insulin-dependent diabetes mellitus (IDDM) (n = 70) presenting with varying degree of metabolic control and status of diabetic late complications, and were compared with age-matched healthy subjects (n = 70) in a cross-sectional study. Concentrations of cICAM-1 and cVCAM-1 were elevated in IDDM vs. age-matched controls (cICAM-1: 276 +/- 71 vs. 212 +/- 57 ng/mL; P < 0.0001; cVCAM-1: 781 +/- 245 vs. 615 +/- 151 ng/mL; P < 0.0001), whereas cELAM-1 did not differ between the groups (cELAM-1: 50 +/- 25 vs. 46 +/- 23 ng/mL, P = 0.31). The levels of cVCAM-1 were more markedly elevated in IDDM patients with diabetic retinopathy (n = 32) than in those without (n = 38) (cVCAM-1: 848 +/- 281 vs. 724 +/- 197 ng/mL, P < 0.05), as well as in patients with micro- or macroalbuminuria (n = 10) vs. those without (n = 60) (cVCAM-1: 947 +/- 256 ng/mL vs. 753 +/- 234 ng/mL, P < 0.05), whereas no difference in cICAM-1 and cE...Continue Reading

Citations

Jul 1, 2011·Journal of Assisted Reproduction and Genetics·Pervin VuralMüjdat Uysal
May 5, 2011·American Journal of Physiology. Endocrinology and Metabolism·Justin L Rains, Sushil K Jain
Feb 24, 2007·Vascular Health and Risk Management·Ted WuAlison K Death
Jan 25, 2014·Journal of Endocrinological Investigation·M M Roca-RodríguezM Aguilar-Diosdado
Nov 1, 2011·Current Diabetes Reports·Shannon D SullivanRobert Ratner
Feb 3, 2016·Frontiers of Medicine·Marijke A de VriesManuel Castro Cabezas
Apr 17, 2008·Journal of Diabetes and Its Complications·Carin GustavssonCarl-David Agardh
Feb 8, 2011·Diabetic Medicine : a Journal of the British Diabetic Association·A ZawiejskaJ Brązert
Jul 6, 2016·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·Márta KaszaV Nagy
Mar 27, 2015·Journal of Cellular Physiology·Samar A SultanAnne M Graham
Nov 11, 2009·Diabetic Medicine : a Journal of the British Diabetic Association·M StadlerR Prager
Dec 3, 2014·Journal of Diabetes and Its Complications·Hussein A RajabUNKNOWN DCCT/EDIC Group of Investigators
Apr 25, 2006·Journal of Diabetes and Its Complications·Sabita S Soedamah-MuthuUNKNOWN EURODIAB Prospective Complications Study group
Jan 28, 2017·Journal of the American College of Cardiology·Giuseppe PattiRaffaele De Caterina
Jul 23, 2003·Journal of Thrombosis and Haemostasis : JTH·G JörneskogM Blombäck
May 19, 2006·Journal of the American Podiatric Medical Association·Javier La FontainePaula K Shireman
Dec 17, 1997·The Journal of Clinical Endocrinology and Metabolism·A Kautzky-WillerO F Wagner
Feb 16, 2021·Frontiers in Pharmacology·Alessandra MiceraMarco Coassin

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.